Amylyx Pharmaceuticals, Inc. (AMLX)
13.88
-0.22
(-1.60%)
USD |
NASDAQ |
Mar 06, 16:00
13.88
0.00 (0.00%)
After-Hours: 20:00
Amylyx Pharmaceuticals Free Cash Flow : -123.48M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Rapt Therapeutics, Inc. | -86.66M |
| Disc Medicine, Inc. | -181.33M |
| Cytokinetics, Inc. | -534.82M |
| Ionis Pharmaceuticals, Inc. | -325.67M |
| MediciNova, Inc. | -9.813M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -27.90M |
| Cash from Investing (Quarterly) | 29.47M |
| Cash from Financing (Quarterly) | -0.208M |
| Free Cash Flow Per Share (Quarterly) | -0.2548 |
| Free Cash Flow to Equity (Quarterly) | -28.01M |
| Free Cash Flow to Firm (Quarterly) | -27.99M |
| Free Cash Flow Yield | -9.42% |